Cargando…
Detection of Cell Types Contributing to Cancer From Circulating, Cell-Free Methylated DNA
Detection of cellular changes in tissue biopsies has been the basis for cancer diagnostics. However, tissue biopsies are invasive and limited by inaccuracies due to sampling locations, restricted sampling frequency, and poor representation of tissue heterogeneity. Liquid biopsies are emerging as a c...
Autores principales: | Barefoot, Megan E., Loyfer, Netanel, Kiliti, Amber J., McDeed, A. Patrick, Kaplan, Tommy, Wellstein, Anton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353442/ https://www.ncbi.nlm.nih.gov/pubmed/34386036 http://dx.doi.org/10.3389/fgene.2021.671057 |
Ejemplares similares
-
Circulating cell-free methylated DNA reveals tissue-specific, cellular damage from radiation treatment
por: McNamara, Megan E., et al.
Publicado: (2023) -
35 Novel statistical methods to unlock the clinical potential of liquid biopsy sampling
por: McDeed, Arthur Patrick, et al.
Publicado: (2023) -
Impaired CXCL12 signaling contributes to resistance of pancreatic cancer subpopulations to T cell-mediated cytotoxicity
por: Lin, Yuan-Na, et al.
Publicado: (2022) -
Remote immune processes revealed by immune-derived circulating cell-free DNA
por: Fox-Fisher, Ilana, et al.
Publicado: (2021) -
Cardiomyocyte-specific circulating cell-free methylated DNA in esophageal cancer patients treated with chemoradiation
por: Roth, Sarah Martinez, et al.
Publicado: (2021)